fda compounding semaglutide crackdown news today 2025 US signals on compounded weight-loss drugs; Hims shares tumble FDA proposes a new GLP-1

Publication Details Paper Title: Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation | Authors: Huilin Tang, Bingyu Zhang, Yiwen Lu, Dazheng Zhang, Ruishan Liu, Yuan Lu, George Cotsarelis, David A

In 2018, there were fewer than five GLP-1 prescriptions per 10,000 women after giving birth

226 YoungJ

Animal study doses cannot be extrapolated to other species due to profound differences in melanocortin receptor expression, distribution, pharmacokinetics, metabolic rates, and species-specific neural circuit organization

Can I combine IV therapy with other aesthetic treatments